Digital Measures for Clinical Trial Endpoints in Huntington's Disease

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

June 20, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

September 30, 2026

Conditions
Huntington DiseaseHealthy
Interventions
DEVICE

ActiGraph LEAP

The ActiGraph LEAP has received 510(k) clearance from the US FDA and offers extensive sensor collections, providing continuous digital measures of activity, sleep, mobility, and additional vital signs, including heart rate and variability, oxygen saturation, and skin temperature, in a single fit-for-purpose device.

DEVICE

Axivity AX6

The Axivity AX6 is a data logger capable of recording raw data from a suite of integrated sensors. It features a state of the art 6-Axis movement sensor measuring linear acceleration and angular velocity at high precision. All sensor locations and Orientations are identical to the AX3 for maximum compatibility. All data is stored in its raw, unaltered format on the embedded flash memory.

Trial Locations (1)

14642

RECRUITING

University of Rochester Medical Center, Rochester

All Listed Sponsors
collaborator

Food and Drug Administration (FDA)

FED

lead

University of Rochester

OTHER

NCT07010705 - Digital Measures for Clinical Trial Endpoints in Huntington's Disease | Biotech Hunter | Biotech Hunter